Prospective study on optimal number of passes in endoscopic-ultrasound guided fine needle biopsy for pancreatic masses

Prospective study on optimal number of passes in endoscopic-ultrasound guided fine needle biopsy for pancreatic masses - Optimal number of passes in EUS-FNB for pancreatic masses

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028273

Enrollment

100

Registered

2017-07-19

Start date

2017-07-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic masses

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with a solid pancreatic mass which required EUS-FNB

Exclusion criteria

Exclusion criteria: 1)Case with severe comorbidity in any other organs 2)Case of Performance Status 4 3)Case having difficulty in endoscopic approach 4)Case with coagulopathy 5)Pregnant women or those suspected of pregnancy 6)Age<20 7)Case without informed consent 8)Cases considered ineligible by attending physicians

Design outcomes

Primary

Measure	Time frame
Cumulative sensitivity and optimal numbers of needle passes	—

Countries

Japan

Contacts

Public ContactTadahisa Inoue

Aichi Medical University School of Medicine Department of Gastroenterology

tinoue-tag@umin.ac.jp0561-62-3311

Outcome results